Who are bioAffinity Technologies, Inc.'s main suppliers?

bioAffinity Technologies, Inc. (BIAFW) key suppliers include: Myriad Genetics, Inc., Myriad Genetics, Inc.. View the full supplier network at chainsifter.com/chain/BIAFW.

Who are bioAffinity Technologies, Inc.'s major customers?

bioAffinity Technologies, Inc. (BIAFW) key customers include: Myriad Genetics, Inc., Myriad Genetics, Inc.. View the full customer network at chainsifter.com/chain/BIAFW.

What sector is bioAffinity Technologies, Inc. in?

bioAffinity Technologies, Inc. (BIAFW) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

bioAffinity Technologies, Inc. (BIAFW): 6 Verified Supply Chain Relationships

2Suppliers

2Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

bioAffinity Technologies, Inc. (BIAFW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

3Distinct source URLs

2High confidence

0.780Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

bioAffinity Technologies, Inc. Suppliers

Ticker	Name	Confidence	Evidence
MYGN	Myriad Genetics, Inc.	72%	ddition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent’s claims narrowly, or refuse to stop the o…
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from BIAFW graph: ddition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, …

bioAffinity Technologies, Inc. Customers

Ticker	Name	Confidence	Evidence
MYGN	Myriad Genetics, Inc.	72%	e, handling, or disposal of these materials. In the event of contamination or injury, PPLS could be held liable for any resulting damages, and any liability could exceed its resources or any applicab…
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from BIAFW graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from BIAFW graph: Reciprocal relationship from MYGN…

bioAffinity Technologies, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
BIAFW-DEBT-8189	Warrants outstanding: 3255840	90%	xbrl warrant detail from xbrl 2025-09-30.
BIAFW-DEBT-8190	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2022-12-31.

bioAffinity Technologies, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for bioAffinity Technologies, Inc..

bioAffinity Technologies, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for bioAffinity Technologies, Inc..

bioAffinity Technologies, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
MYGN	Myriad Genetics, Inc.	100.00	1	['customer', 'supplier']
BNR	Burning Rock Biotech Limited	50.00	2
FLGT	Fulgent Genetics, Inc.	50.00	2
CSTL	Castle Biosciences, Inc.	50.00	2
BNTC	Benitec Biopharma Inc.	50.00	2
CALC	CalciMedica, Inc.	50.00	2
ALLO	Allogene Therapeutics, Inc.	50.00	2
CTMX	CytomX Therapeutics, Inc.	50.00	2
CABA	Cabaletta Bio, Inc.	50.00	2
SDGR	Schrödinger, Inc.	50.00	2
BCDA	BioCardia, Inc.	50.00	2
ELVN	Enliven Therapeutics, Inc.	50.00	2
ATYR	aTyr Pharma, Inc.	50.00	2
BIAF	bioAffinity Technologies, Inc.	50.00	2
DSGN	Design Therapeutics, Inc.	50.00	2
IMNM	Immunome, Inc.	50.00	2
PSNL	Personalis, Inc.	50.00	2
HOWL	Werewolf Therapeutics, Inc.	50.00	2
GH	Guardant Health, Inc.	50.00	2
BIOA	BioAge Labs, Inc.	50.00	2

bioAffinity Technologies, Inc. Supply Chain